Portfolio · Therapeutic Category L

Antineoplastic & Immunomodulating Agents

"The newest generation of hope, sourced faster."

Oncology care setting, infusion room or lab, warm light

Cancer claims nearly 10 million lives a year, patients need medicines that bring genuine progress, not just savings.

Cancer causes nearly 10 million deaths worldwide every year, almost one in six of all deaths. That's why this category brings together high-quality generic, biosimilar, and innovative oncology medicines: genuine therapeutic advancement over current standard-of-care, not just cost savings, matters more here than almost anywhere else in our portfolio.

Source: World Health Organization, Cancer Fact Sheet, 2024.

Products in This Category

Filter by Product Type

Development Stage Sourcing Dossier Review Dossier Screening Product Submission Approval Launch

12 product(s) found

Product	Indication	Product Type	Dosage Form	Development Stage
Oxaliplatin50 mg/10 mL; 100 mg/20 mL	Metastatic colorectal cancer	Generic	Injection	Dossier Review
Gefitinib250 mg	Non-small cell lung cancer	Generic	Tablet	Dossier Screening
Pomalidomide1 mg; 2 mg; 3 mg; 4 mg	Multiple myeloma	Generic	Capsule	Sourcing
Lenalidomide5 mg; 10 mg; 25 mg	Multiple myeloma	Generic	Capsule	Dossier Review
Imatinib100 mg; 400 mg	Chronic myeloid leukaemia	Generic	Tablet	Product Submission
Dasatinib50 mg; 100 mg	Chronic myeloid leukaemia	Generic	Tablet	Dossier Screening
Abiraterone250 mg	Metastatic prostate cancer	Generic	Tablet	Dossier Review
Filgrastim300 mcg/0.5 mL; 480 mcg/0.8 mL	Febrile neutropenia	Biosimilar	Pre-filled syringe	Sourcing
Pegfilgrastim6 mg/0.6 mL	Febrile neutropenia	Biosimilar	Pre-filled syringe	Sourcing
Rituximab100 mg/10 mL; 500 mg/50 mL	Non-Hodgkin lymphoma, CLL	Biosimilar	Infusion	Dossier Review
Bevacizumab100 mg/4 mL; 400 mg/16 mL	mCRC, non-small cell lung cancer	Biosimilar	Infusion	Sourcing
Adalimumab40 mg/0.8 mL; 40 mg/0.4 mL	Rheumatoid arthritis, psoriasis, IBD	Biosimilar	Pre-filled syringe	Sourcing